Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 56Breast 25Thoracic 19Head & Neck 19CNS 15Genitourinary 13Gynecologic 9Sarcoma 7Other solid neoplasm 6Other neoplasm 4Dermatologic 4Tumor-Agnostic 3Lymphoid 3Plasma cell 2Other hematologic neoplasm 2Myeloid 2Other 1Endocrine 1Classical hematology 1

Conditions

Neoplasms 1Neoplasm Metastasis 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Celecoxib × Tumor-Agnostic × Clear all
NCT03864575 2019-07-12

NICE-COMBO

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Unknown
68 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00596219 2015-12-23

Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma

Memorial Sloan Kettering Cancer Center

Phase NA Completed
12 enrolled
Tumor-Agnostic

Carcinoma, Carcinoma, Squamous Cell

NCT00165451 2011-07-07

A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
20 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡